Seroconversion after measles vaccination at nine and fifteen months of age


Isik N., Uzel N., Gokcay G. , Kilic A., Yilmaz G., Sadikoglu B., ...More

PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol.22, no.8, pp.691-695, 2003 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 8
  • Publication Date: 2003
  • Doi Number: 10.1097/01.inf.0000078158.23337.ed
  • Journal Name: PEDIATRIC INFECTIOUS DISEASE JOURNAL
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.691-695
  • Keywords: measles, revaccination, immunogenicity, infant, children, RUBELLA MMR VACCINE, IMMUNE-RESPONSE, CHILDREN, INFANTS, IMMUNOGENICITY, IMMUNIZATION, ANTIBODY, REVACCINATION, FAILURE

Abstract

Background. Despite high vaccination coverage, single dose measles immunization programs have been unsuccessful in eliminating the disease. Because seroconversion rates are lower in infants vaccinated before 12 months of age, a second dose of measles vaccine is recommended at 15 months. The aim of this study was to determine the seroconversion rates in children after the first and second doses of measles vaccinations at 9 and 15 months of age.